Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Neoplasms × TER 286 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Trastuzumab 318 Paclitaxel 299 Cyclophosphamide 280 Docetaxel 258 Capecitabine 168 Doxorubicin 159 Letrozole 153 Tamoxifen 133 Bevacizumab 109 Fulvestrant 107 Lapatinib 105 Carboplatin 101 exemestane 100 Anastrozole 100 Radiotherapy 96 Gemcitabine 90 Epirubicin 89 palbociclib 73 Vinorelbine 69 Fluorouracil 66 Surveys and Questionnaires 64 Exercise 64 pertuzumab 59 Albumin-Bound Paclitaxel 58 Filgrastim 56 Magnetic Resonance Spectroscopy 54 eribulin 52 Everolimus 49 Blood Specimen Collection 46 Taxes 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00035841 2011-07-25

Phase 2 Study of TLK286 in Metastatic Breast Cancer

Telik

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡